Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 64
Healthy volunteers: yes

Brief summary:
To investigate the bioequivalence of telmisartan administrated in two different ways: both in telmisartan 80 mg/amlodipine 5 mg fixed-dose combination tablets (T) and as telmisartan 80 mg tablet and amlodipine 5 mg tablets (R) in concomitant use

Detailed description:
Purpose:

Arms:
arm 1: single-dose, four-period replicated crossover design arm 2: single-dose, four-period replicated crossover design

Interventions: intervention 1: Telmisartan/Amlodipin FDC intervention 2: Telmisartan intervention 3: Amlodipin
Intervention descriptions: intervention 1: Telmisartan80mg/Amlodipin5mg FDC intervention 2: Telmisartan 80 mg tablet intervention 3: Amlodipin 5mg tablet

Protocol document: